A Reappraisal of the Utility of Somatostatin Receptor Scintigraphy in Patients with Ectopic Adrenocorticotropin Cushing's Syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 10, 2003, Pages 4754-4758

  Tsagarakis, S ^a   Christoforaki, M ^a   Giannopoulou, H ^a   Rondogianni, F ^a   Housianakou, I ^a   Malagari, C ^a,b   Rontogianni, D ^a   Bellenis, I ^a   Thalassinos, N ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOSCAN R; PENTETREOTIDE IN 111;

ADULT; ARTICLE; BRONCHUS CARCINOID; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CUSHING SYNDROME; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCINTIGRAPHY; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; THYROID MEDULLARY CARCINOMA; TUMOR LOCALIZATION; VALIDATION PROCESS;

ADRENOCORTICOTROPIC HORMONE; ADULT; BRONCHIAL NEOPLASMS; CARCINOID TUMOR; CARCINOMA, MEDULLARY; CUSHING SYNDROME; FEMALE; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; THYROID NEOPLASMS;

BRONCHUS;

EID: 0242288595     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030525     Document Type: Article

References (25)

1. Orth DN 1995 Cushing's syndrome. N Engl J Med 332:791-803
2. Wajchenberg BL, Mendonca BB, Liberman B, Pereira MA, Carneiro PC, Wakamatsu A, Kirschner MA 1994 Ectopic adrenocorticotropic hormone syndrome. Endocr Rev 15:752-787
3. Findling JW, Doppman JL 1994 Biochemical and radiologic diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 23:551-537
4. Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM 1986 Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) 24:699-713
5. Doppman JL 1994 Somatostatin receptor scintigraphy and the ectopic ACTH syndrome. The solution or just another test? Am J Med 96:303-304
6. Iser G, Pfohl M, Dörr U, Weiss EM, Seif FJ 1994 Ectopic ACTH secretion due to a bronchopulmonary carcinoid localized by somatostatin receptor scintigraphy. Clin Invest 72:887-891
7. Phlipponneau M, Nocaudie M, Epelbaum J, De Keyzer Y, Lalau JD, Marchandise X, Bertagna X 1994 Somatostatin analogs for the localization an preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. J Clin Endocrinol Metab 78:20-24
8. Weiss M, Yellin A, Husza'r M, Eisenstein Z, Bar-Ziv J, Krausz Y 1994 Localization of adrenocorticotropic hormone-secreting bronchial carcinoid tumor by somatostatin-receptor scintigraphy. Ann Intern Med 121:198-199
9. Lefebvre H, Jegou S, Leroux P, Dero M, Vaudry H, Kuhn JM 1995 Characterization of the somatostatin receptor subtype in a bronchial carcinoid tumor responsible for Cushing's syndrome. J Clin Endocrinol Metab 80:1423-1428
10. Tsagarakis S, Giannakenas C, Vassilakos PJ, Platis O, Belenis I, Kaskarelis J, Rontoyianni D, Thalassinos N 1995 Successful localization of an occult ACTH-secreting bronchial carcinoid tumour with 111 indium-DTPA labelled octreotide. Clin Endocrinol (Oxf) 43:763-767
11. Christin-Maitre S, Chabbert-Buffet N, Mure A, Boukhris R, Bouchard P 1996 Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor. Chest 109:845-846
12. Kristoffersson A, Olsson T, Björnebrink J, Hägg E 1996 Diagnosis of ectopic ACTH production from a bronchial carcinoid by imaging with octreotide scintigraphy. Eur J Surg 162:515-518
13. Briganti V, Mannelli M, La Cava G, Peri A, Meldolesi U, Masi R, Pupi A 1997 Characterizing an ectopic secreting carcinoid with indium-111-DTPA-n- Phepentetreotide. J Nucl Med 38:711-714
14. 111In-DTPA labelled octreotide scintigraphy. J Endocrinol Invest 20:327-330
15. 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid. Eur J Endocrinol 137:688-690
16. Segu VB, Mahvi DM, Wilson MA, Hale SJ, Warner TF, Meredith M, Shenker Y 1997 Use of In-111 pentetreotide scintigraphy in the diagnosis of a midgut carcinoid causing Cushing's syndrome. Eur J Endocrinol 137:79-83
17. Matte J, Roufosse F, Rocmans P, Schoutens A, Jacobovitz D, Mockel J 1998 Ectopic ACTH syndrome and pulmonary carcinoid tumour identified by [111-In-DTPA-D-Phe1] octreotide. Postgrad Med J 74:108-114
18. 111In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J Clin Endocrinol Metab 84:1186-1192
19. Tabarin A, Valli N, Chanson P, Bachelot Y, Rohmer V, Bex-Bachellerie V, Catargi B, Roger P, Laurent F 1999 Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 84:1193-1202
20. Tsagatakis S, Kaskarelis IS, Kokkoris P, Malagari C, Thalassinos N 2000 The application of combined stimulation with CRH and desmopressin during bilateral petrosal sinus sampling in patients with Cushing's syndrome. Clin Endocrinol (Oxf) 52:355-361
21. Kaltsas T, Krassas GE, Pontikides N, Tsotsia E, Tsagarakis S 2003 Cyclical Cushing syndrome caused by intermittent ectopic ACTH hormonogenesis responsive to somatostatin analogues. Endocrinologist 13:7-11
22. De Herder WW, Krenning EP, Malchoff CD, Hofland L, Reubi J-C, Kwekkeboom DJ, Oei HY, Pols HAP, Bruining HA, Nobels FRE, Lamberts SWJ 1994 Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. Am J Med 96:305-312
23. Lamberts SWJ, De Herder WW, Hofland LJ 2002 Somatostatin analogs in the diagnosis and treatment of cancer. Trends Endocrinol Metab 13:451-457
24. De Herder WW, Lamberts SWJ 1999 Editorial: tumor localization: the ectopic ACTH syndrome. J Clin Endocrinol Metab 84:1184-1185
25. Stalla GK, Brockmeier SJ, Renner U, Newton C, Buchfelder M, Stalla J, Muller OA 1994 Octreotide exerts different effects in vivo and in vitro in Cushing's disease. Eur J Endocrinol 130:125-131